Supplementary_Materials – Supplemental material for The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial

Autor:	Gilleen, James, Nottage, Judith, Yakub, Farah, Kerins, Sarah, Valdearenas, Lorena, Uz, Tolga, Gez Lahu, Tsai, Max, Ogrinc, Frank, Williams, Steve C, Ffytche, Dominic, Mitul A Mehta, Sukhi S Shergill
Rok vydání:	2020
Předmět:	FOS: Psychology FOS: Clinical medicine 170199 Psychology not elsewhere classified 110319 Psychiatry (incl. Psychotherapy) 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 110904 Neurology and Neuromuscular Diseases
DOI:	10.25384/sage.12893669
Popis:	Supplemental material, Supplementary_Materials for The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial by James Gilleen, Judith Nottage, Farah Yakub, Sarah Kerins, Lorena Valdearenas, Tolga Uz, Gez Lahu, Max Tsai, Frank Ogrinc, Steve C Williams, Dominic Ffytche, Mitul A Mehta and Sukhi S Shergill in Journal of Psychopharmacology
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3043459fd074fa0ccfab682ed14e6c6b Zobrazit plný text záznamu